XML 92 R77.htm IDEA: XBRL DOCUMENT v3.22.4
CAPITAL STOCK - PERFORMANCE AND RESTRICTED STOCK (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Granted (in dollars per share) $ 14.43 $ 29.56 $ 16.19
Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested, period start (in shares) 254,800    
Granted (in shares) 0    
Vested (in shares) 244,800    
Forfeited (in shares) (5,000)    
Exercised (in shares) (5,000)    
Non-vested, period end (in shares)   254,800  
Exercisable at end of period (in shares) 93,750    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Nonvested, at period start (in dollars per share) $ 79.71    
Granted (in dollars per share) 0    
Forfeited (in dollars per share) 60.94    
Exercised (in dollars per share) 60.94    
Vested (in dollars per share) 80.48    
Nonvested, at period end (in dollars per share)   $ 79.71  
Exercisable at end of period (in dollars per share) $ 60.94    
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested, period start (in shares) 6,000    
Granted (in shares) 26,173    
Vested (in shares) 0    
Forfeited (in shares) (243)    
Non-vested, period end (in shares) 31,930 6,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Nonvested, at period start (in dollars per share) $ 172.11    
Granted (in dollars per share) 100.97 $ 207.24 $ 87.29
Forfeited (in dollars per share) 127.09    
Vested (in dollars per share) 0    
Nonvested, at period end (in dollars per share) $ 114.14 $ 172.11  
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested, period start (in shares) 493,513    
Granted (in shares) 78,236    
Vested (in shares) 114,991    
Forfeited (in shares) (14,239)    
Non-vested, period end (in shares) 442,519 493,513  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Nonvested, at period start (in dollars per share) $ 141.98    
Granted (in dollars per share) 115.91    
Forfeited (in dollars per share) 91.17    
Vested (in dollars per share) 90.57    
Nonvested, at period end (in dollars per share) $ 152.36 $ 141.98